Kezar Life Sciences, Inc.

This study tested a drug called zetomipzomib in people with active lupus nephritis, a kidney disease caused by lupus. The goal was to see if the drug could improve kidney function better than a placebo over 52 weeks. The trial was terminated early, so results are limited. Partici…

This early-phase study tested a new drug called KZR-261 in 61 people with advanced solid tumors (like melanoma, colorectal, or prostate cancer) that had stopped responding to standard treatments. The main goals were to check the drug's safety, find the best dose, and see if it co…